GUJARAT THEMIS BIOSYN LTD Share Price

Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The Company operates through pharmaceuticals segment. Its product portfolio comprises Rifamycin-S and Lovastatin. The Company is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy). As of 26 May 2026, GUJARAT THEMIS BIOSYN LTD share price is ₹389.35. The stock opened at ₹379.00, compared to its previous close of ₹368.70. During today's trading session, GUJARAT THEMIS BIOSYN LTD share price moved in the range of ₹377.00 to ₹401.90, with an average price of ₹389.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹377.00 and a high of ₹401.90. On the performance front, GUJARAT THEMIS BIOSYN LTD share price has declined by 5.21% over the last six months and is up 28.67% on a year-on-year basis.

The market capitalization of GUJARAT THEMIS BIOSYN LTD is ₹4,019 Crs, with a P/E ratio of 84.0 and a dividend yield of 0.18%.